Occupational asthma in a pharmaceutical worker exposed to hydralazine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2281435.
- Also identified by PMC identifier 462853.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A pharmaceutical worker developed asthma when exposed to hydralazine, an antihypertensive drug. The diagnosis of occupational asthma was supported by specific inhalation challenges, which produced a late asthmatic reaction and an increase in bronchial responsiveness. No evidence of an IgE or an IgG dependent mechanism could be found.
Medical subject headings
- Asthma
- Drug Industry
- Hydralazine
- Occupational Diseases
- Occupational Exposure